MC
CELG

Marcus Capital’s Celgene Corp CELG Stock Holding History

Marcus Capital’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		$756K Sell
8,450
-250
-3% -$22.1K 2.2% 20
2018
Q2 		$691K Buy
8,700
+3,000
+53% +$249K 2.2% 21
2018
Q1 		$508K Buy
5,700
+2,625
+85% +$252K 1.87% 24
2017
Q4 		$321K Sell
3,075
-3,700
-55% -$417K 1.23% 32
2017
Q3 		$988K Sell
6,775
-4,925
-42% -$671K 1.4% 31
2017
Q2 		$1.52M Buy
11,700
+150
+1% +$18.4K 1.3% 38
2017
Q1 		$1.44M Buy
11,550
+175
+2% +$20.9K 1.34% 35
2016
Q4 		$1.32M Buy
11,375
+75
+0.7% +$8.35K 1.42% 32
2016
Q3 		$1.18M Sell
11,300
-5,150
-31% -$557K 1.13% 40
2016
Q2 		$1.62M Buy
16,450
+50
+0.3% +$5.17K 1.71% 29
2016
Q1 		$1.64M Buy
16,400
+550
+3% +$56.6K 1.81% 25
2015
Q4 		$1.9M Buy
+15,850
New +$1.83M 2.02% 25

Other funds holding CELG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Marcus Capital's CELG Position: Q3 2018 in Review

Marcus Capital reduced its Celgene Corp (CELG) stake by 2.9% in Q3 2018, selling an estimated $22.1K and leaving 8,450 shares worth $756K. The position accounts for 2.2% of the portfolio, ranked #20.

Marcus Capital first reported a position in CELG in Q4 2015 and has held it in 12 quarters since. The position peaked at $1.9M in Q4 2015. 1,364 funds tracked by Wall St. Rank hold CELG as of Q3 2018.

  • Marcus Capital held 8,450 shares of Celgene Corp worth $756K as of Q3 2018.
  • Marcus Capital sold 250 Celgene Corp shares in Q3 2018, an estimated $22.1K.
  • Celgene Corp made up 2.2% of Marcus Capital's portfolio in Q3 2018, its #20 holding.
  • Marcus Capital first reported a position in Celgene Corp in Q4 2015 and has held it in 12 quarters since.
  • Marcus Capital's Celgene Corp position peaked at $1.9M in Q4 2015.
  • 1,364 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2018.

Based on Marcus Capital's 13F filing for Q3 2018, filed 13 Nov 2018.